Skip to content
healthcare.dev

Abacavir

NDC 31722-557, Abacavir, tablet, from Camber Pharmaceuticals, Inc..

Product NDC
31722-557
Status
Listed
Labeler
Camber Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA091560
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/31722-557 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ABACAVIR SULFATE300 mg/1

Pharmacologic classes

Cytochrome P450 1A1 Inhibitors [MoA]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
31722-557-603172205576060 TABLET in 1 BOTTLE (31722-557-60)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/44fb1e25-ad03-4a7f-9f35-2e29f5025661
  • NADAC price for package 31722055760

    GET /v1/drugs/nadac/31722055760

Use it

Look up 31722-557 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/31722-557 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 31722-557. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.